发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND TERIFLUNOMIDE. |
摘要 |
This invention provides a method of treating a subject afflicted with multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising administering to the subject laquinimod as an add-on therapy to or in combination with a greater than minimal effective dose of teriflunomide. This invention also provides a package and a pharmaceutical composition comprising laquinimod and a greater than minimal effective dose of teriflunomide for treating a subject afflicted with MS or presenting a CIS. This invention also provides laquinimod for use as an add-on therapy or in combination with a greater than minimal effective dose of teriflunomide in treating a subject afflicted with MS or presenting a CIS. This invention further provides use of laquinimod and a greater than minimal effective dose of teriflunomide in the preparation of a combination for treating a subject afflicted with MS or presenting a CIS. |
申请公布号 |
MX2016008214(A) |
申请公布日期 |
2016.10.14 |
申请号 |
MX20160008214 |
申请日期 |
2014.12.23 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
Volker KNAPPERTZ |
分类号 |
A61K31/4704;A61K31/277;C07C255/44 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|